Hepatitis B hos børn

Vibeke Brix Christensen, Sannie Brit Nordly, Mette Kjær, Marianne Hørby Jørgensen

Abstract

Chronic hepatitis B (HBV) infection is seen in 400 million persons worldwide. HBV is transmitted vertically or horizontally by infected blood and body fluids. An effective vaccine exists. Most children develop a chronic HBV infection if infected early in life. They are often in an immune-tolerant phase with no indication for antiviral treatment. Antiviral treatment with interferon or a nucleotide analogue is a possibility if the HBV infected child develops into a phase of immune activation. HBV infection can lead to liver cirrhosis and hepatocellular carcinoma.

Bidragets oversatte titelHepatitis B infection in children.
OriginalsprogDansk
ArtikelnummerV02130135
TidsskriftUgeskrift for Laeger
Vol/bind176
Udgave nummer8
Sider (fra-til)726-729
Antal sider4
ISSN0041-5782
StatusUdgivet - 14 apr. 2014

Fingeraftryk

Dyk ned i forskningsemnerne om 'Hepatitis B hos børn'. Sammen danner de et unikt fingeraftryk.

Citationsformater